Netflix’s $72bn takeover of Warner Brothers is a blockbuster in every sense.
The private equity backer of Burger King UK is weighing a takeover bid for Advanced Medical Solutions Group, a London-listed producer of surgical products.
Sky News has learnt that Bridgepoint is exploring an offer for AMS which could value the target at somewhere in the region of £550m-£600m.
Banking sources said the buyout firm was examining a bid valuing AMS at between 270p and 280p per share, a premium of more than 30% to its current share price.
Money latest: The 10 happiest places to live in the UK
It was unclear on Friday morning whether it had made a formal approach to the board of AMS.
News of Bridgepoint's interest comes months after Montagu Private Equity abandoned its interest in a bid for the company.
Inflexion, another private equity investor, had also been studying a potential offer last year.
Netflix agrees blockbuster $72bn deal for Warner Bros studios
Netflix flexes its muscles and could yet get its way in Trump's America
Oil prices are down but fuel prices aren't - here's why
Be the first to get Breaking News
Install the Sky News app for free
AMS Group manufactures surgical brands including LiquiBand and Resorba.
Listed on London's junior AIM stock market, the company reported interim results in September showing a 49% rise in pre-tax profit.
Its shares have been broadly flat over the last year, and on Friday morning were trading at around 208.5p, giving it a market capitalisation of £455m.
Bridgepoint and AMS both declined to comment.
